drugset / Trial / NCT04032119
RCT of Gastric ESD With or Without Epineprhine Added Solution
Phase 3
Completed
800 enrolled
Chinese University of Hong Kong
Changi General Hospital · collabFukuoka University · collabIshikawa Prefectural Central Hospital · collabJCHO Osaka Hospital · collabJapan Community Healthcare Organization Osaka Hospital · collabKosin University Gospel Hospital · collabKyoto 2nd Red Cross Hospital · collabMachida General Hospital · collabNara City Hospital · collabOsaka International Cancer Institute · collabSapporo Kinentou hospital · collabWakayama Red Cross Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is an international multi-center randomised controlled study comparing outcomes of gastric endoscopic submucosal dissection (ESD) with or without addition of epinephrine in the submucosal injection solution.
Timeline
- Start
- 2020-01-10
- Primary completion
- 2022-12-31
- Completion
- 2023-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epinephrine | Other / unclassified | 0.2 ml | Other |